Skip to main content
SpringerLink
Log in

Pharmakotherapie bei Zwangsstörungen

  • Conference paper
Spektrum der Zwangsstörungen

  • 172 Accesses

Zusammenfassung

Die Zwangsstörung wurde lange Zeit als eine chronische, auch durch pharmakotherapeutische Maßnahmen wenig beeinflußbare Erkrankung angesehen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bach M, Aigner M, Lenz G (1997) Risperidone as adjunct to fluoxetine treatment of OCD patients with psychotic features. Pharmacopsychiatr 30: 28–29

    Article  CAS  Google Scholar 

  • Bisserbe JC, Wiseman RL, Goldberg MS, Lane RM (1995) A double blin0064 comparison of sertraline and clomipramine in outpatients with OCD. Abstract, 148th Annual Meeting of the American Psychiatric Association, Miami, Florida

    Google Scholar 

  • Fallon BA, Campeas R, Schneier FR et al. (1992) Open trial of intravenous clomipramine in five treatment refractory patients with obsessive compulsive disorder. J Neuropsychiatry 4: 70–75

    CAS  Google Scholar 

  • Foa EB, Kozak MJ (1996) Psychological treatment for obsessive compulsive disorder. In: Mavissakalian MR, Prien RF (eds) Long-term treatment of anxiety disorders. American Psychiatric Press, Washington, pp 285–309

    Google Scholar 

  • Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Henninger GR, Charney DS (1989) The Yale-Brown obsessive-compulsive scale (Y-BOCS), part I. Development, use, and reliability Arch Gen Psychiatry 46: 1006–1011

    PubMed  CAS  Google Scholar 

  • Goodman WK, Kozak MJ, Liebowitz M, White KL (1996) Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial. Int Clin Psychopharmacol 11: 21–29

    Article  PubMed  CAS  Google Scholar 

  • Greist JH, Jefferson JW, Kobak KA, Chouinard G, Duboff E, Halaris A, Kim SW, Koran L, Liebowitz MR, Lydiard B, McElroy S, Mendels J, Rasmussen S, White K, Flicker C (1995a) A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol 10: 57–65

    Article  PubMed  CAS  Google Scholar 

  • Greist JH, Jenike MA, Robinson D, Rasmussen SA (1995) Efficacy of fluvoxamine in obsessive-compulsive disorder: results of a multicentre, double-blind, placebo-controlled trial. Eur J Clin Res 7: 195–204

    Google Scholar 

  • Hand I, Büttner-Westphal (1991) Die Yale-Brown obsessive-compulsive Scale (Y-BOCS). Ein halb- strukturiertes Interview zur Beurteilung des Schweregrades von Denk- und Handlungszwängen. Verhaltenstherapie 1: 223–233

    Google Scholar 

  • Hewlett W, Vinogradov S, Agras W (1992) Clomipramine, clonazepam and Clonidine treatment of obsessive compulsive disorder. J Clin Psychopharmacol 12: 420–430

    Article  PubMed  CAS  Google Scholar 

  • Hollander E, De Caria CM, Schneier FR et al. (1990) Fenfluramin augmentation of serotonin reuptake blockade antiobsessional treatment. J Clin Psychiatry 51: 119–123

    PubMed  CAS  Google Scholar 

  • Jacobsen FM (1995) Risperidone in the treatment of affective illness and obsessive-compulsive disorder. J Clin Psychiatry 56: 423–429

    PubMed  CAS  Google Scholar 

  • Koran LM, McElroy SL, Davidson JRT, Rasmussen SA, Hollander E, Jenike MA (1996) Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. J Clin Psychopharmacol 16: 121–129

    Article  PubMed  CAS  Google Scholar 

  • Lopez-Ibor Jr JJ, Fernandez-Cordoba E (1967) La monoclorimipramina en enfermos psiquiátricos resistentes a otros tratamientos. Actas Luso-Espanolas de Neurología, Psiquiatria y Ciencias Afines 26, 2: 119–147

    Google Scholar 

  • McDougle CJ, Goodman WK, Price LH, Delgado PL, Krystal JH, Charney DS, Heninger GR (1990) Neuroleptic addition in fluvoxamine refractory obsessive compulsive disorder. Am J Psychiatry 147: 652–654

    PubMed  CAS  Google Scholar 

  • McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH (1994) Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 51: 302–308

    PubMed  CAS  Google Scholar 

  • Montgomery SA, Mclntyre A, Osterheider M, Sarteschi P, Zitterl W, Zohar J, Birkett M, Wood AJ and the Lilly European OCD Study Group (1993) A double-blind, placebo controlled study of fluoxetine in patients with DSM-III-R obsessive compulsive disorder. Eur Neuropsychopharmacol 3: 143–152

    Google Scholar 

  • Pato MT, Zohar-Kadouch R, Zohar J (1988) Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am J Psychiatry 145: 1521–1525

    PubMed  CAS  Google Scholar 

  • Pato MT, Hill JL, Murphy DL (1990) A clomipramine dosage reduction in the course of long-term treatment of obsessive-compulsive disorder patients. Psychopharmacol Bull 26: 211–214

    PubMed  CAS  Google Scholar 

  • Piccinelli M, Pini S, Bellantouno C, Wilkinson G (1995) Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. Br J Psychiatry 166: 424–443

    Article  PubMed  CAS  Google Scholar 

  • Pigott TA, L’Heureux F, Rubenstein CS, Hill JL, Murphy DL (1992) A controlled trial of clonazepam augmentation in OCD patients treated with clomipramine or fluoxetine. Abstract, American Psychiatric Association Annual Meeting, Washington DC

    Google Scholar 

  • Pigott TA, Dubbert B, L’Heureux F, Canter S, Murphy DL (1996) Pharmacological treatment for obsessive- compulsive disorder. In: Mavissakalian MR, Prien RF (eds) Long-term treatment of anxiety disorders. American Psychiatric Press, Washington, pp 311–342

    Google Scholar 

  • The Clomipramin Collaborative Study Group (1991) Clomipramine in the treatment of patients with obsessive compulsive disorder. Arch Gen Psychiatry 48: 730–738

    Google Scholar 

  • Tollefson GD, Rampey AH, Potvin JH, Jenike MA, Rush AJ, Dominuguez RA, Koran LM, Shear MK, Goodman W, Genduso LA (1994) A Multicenter investigation of fixed dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 51: 559–567

    PubMed  CAS  Google Scholar 

  • Wheadon DE, Bushnell WD, Steiner M (1993) A fixed dose comparison of 20, 40 or 60mg paroxetine to placebo in the treatment of obsessive compulsive disorder. Poster, American College of Neuro- psychopharmacology Meeting, Puerto Rico, December 1993

    Google Scholar 

  • Zohar J, Judge R and the OCD Paroxetine Study Investigators (1996) Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. Br J Psychiatry 169: 468–474

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. Lenz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Aigner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Bankier
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Sozialpsychiatrie und Evaluationsforschung, Universitätsklinik für Psychiatrie, Währinger Gürtel 18-20, A-1090, Wien, Österreich

    Gerhard Lenz , Ulrike Demal  & Michael Bach ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag/Wien

About this paper

Cite this paper

Lenz, G., Aigner, M., Bankier, B. (1998). Pharmakotherapie bei Zwangsstörungen. In: Lenz, G., Demal, U., Bach, M. (eds) Spektrum der Zwangsstörungen. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7502-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-7502-6_8

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83058-1

  • Online ISBN: 978-3-7091-7502-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation